Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a80a136273e54c4408e5cb9f8e85509a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 |
filingDate |
2010-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2557afffc75f36a0775651092279a7cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7d75d4719f158c1d55bab6330336f51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aaccb878d2b9796c7da0072dcccd08f |
publicationDate |
2012-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20120041168-A |
titleOfInvention |
Means and methods for preventing, preventing and / or measuring heart failure or risk of heart failure |
abstract |
The present invention relates to a method for diagnosing and / or predicting heart failure in a subject, comprising measuring the level of one or more genetic markers that are miRNAs in a bodily fluid sample obtained from the subject. In addition, the present invention provides a method of reducing the expression, amount and / or activity of one or more miRNAs in a subject, or lowering the interaction of one or more miRNAs with their mRNA targets in a subject, or one or more within a subject. A method of treating or preventing heart failure in an individual comprising increasing the expression, amount and / or activity of an mRNA target of miRNA. |
priorityDate |
2009-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |